Stocks gave back earlier gains as a selloff in health care overshadowed the Federal Reserve's decision a day earlier to raise interest rates. Wall Street had rallied on Wednesday after the Fed hiked rates for the third time since 2008. Biogen (BIIB) led health care losses after Morgan Stanley downgraded its rating to EQUAL WEIGHT from OVERWEIGHT. Analysts said they see limited upside for the stock in the near term. Williams-Sonoma (WSM) rose after reporting better-than-expected profit in its fourth quarter. The retailer said the holiday shopping season had been one of its best. Its board also approved a 5% increase to its dividend. Dollar General (DG) bested earnings estimates and reported a healthy increase in same-store sales. The discount retailer also bumped up its dividend by a penny.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.